Robin Snellings, MD

NPI 1235765199ActiveIndividual· Internal Medicine, Infectious Disease· Houston, TX

Internal Medicine, Infectious Disease (MD) in Houston, Texas, trained at Texas A & M University System, Hsc, College of Medicine (class of 2020). Part D covered 153 prescriptions written in 2024, 84% of them generic. Melinta Therapeutics, LLC was the largest of 5 companies reporting payments in 2025, $683.11 in all, mostly food and beverage.

Overview

NPI	1235765199
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Mar 22, 2020
Last updated in NPPES	Sep 9, 2026
Certified by provider	Sep 9, 2026

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Infectious Disease Primary	207RI0200X	T5462	TX
Internal Medicine	207R00000X	T5462	TX
Student in an Organized Health Care Education/Training Program	390200000X	—	—

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Infectious Disease (TX)

Part D prescriptions in 2024

Prescriptions (claims)	153 · 245 30-day fills
Patients	23
Total drug cost	$90,351
Generic share	84% of claims

Medicare sources and data years

Education and affiliations

Medical school	Texas A & M University System, Hsc, College of Medicine
Graduation year	2020
Medicare specialty	Infectious Disease
Telehealth	Offers telehealth